tosufloxacin has been researched along with Muscle Contraction in 1 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, S | 1 |
| Hiraiwa, T | 1 |
| Arai, H | 1 |
| Ono, S | 1 |
| Tanaka, K | 1 |
| Hashiba, K | 1 |
| Nakada, Y | 1 |
| Goden, K | 1 |
| Tanada, K | 1 |
| Maekawa, M | 1 |
1 other study available for tosufloxacin and Muscle Contraction
| Article | Year |
|---|---|
[General pharmacology of T-3262, a new pyridonecarboxylic acid].
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Autonomic Nervous System; Blood | 1989 |